news
stories from the front lines of discovery
From scientific breakthroughs to new open‑source tools, the Allen Institute’s work is reshaping how science is done—and who it’s for. Explore the latest news, stories, and highlights from across our research, partnerships, and open science efforts.
AI BioDesign accelerator combines experimental biology and artificial intelligence to learn nature’s design rules
Researchers from the Allen Institute, University of Washington, and Fred Hutch Cancer Center, supported by Fund for Science and Technology, will build open AI models, datasets, and tools to accelerate biological design for health, sustainability, and other global challenges
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
finding Alzheimer's targets, one cell type at a time
How Shanahan Fellow Iris Stone used her Alzheimer's research and business savvy to chart a path into biotech
No items found.
news
ketamine increases neuroplasticity in female mice but not in males
The surprising finding could help scientists develop better treatments for depression
brain science
news
rogue DNA can move from cell to cell and change how they function
Scientists used Allen Institute cell lines to discover an important new way that cells trade genetic material
cell science
news
Karel Svoboda elected to the Washington State Academy of Sciences
Svoboda’s work has advanced our understanding of the neural mechanisms of learning, movement, and complex brain behavior
neural dynamics
news
SciShots: amber waves of brain
New video illustrates how neural activity in a mouse brain travels in aesthetically pleasing waves and spirals
brain science
science images
BioCentury Grand Rounds conference highlights importance of big data
The conference hosted Nobel Laureates, researchers, and biotech leaders in Seattle looking to advance better treatments in medicine
synthetic biology
immunology
news
science unites us – come see how
Visit the Allen Institute in south Lake Union for hands-on activities for the whole family
No items found.
news
Brain Health accelerator to transform our understanding of brain disorders and develop new treatments
The global collaborative research initiative will initially target Alzheimer’s, Parkinson’s, Huntington’s disease, ALS, and Lewy body dementia
Brain Health
news
Brain Health accelerator: a new way to study brain disease to find new treatments for it
Understanding brings hope—a new global research initiative to understanding the cells and circuits that drive brain disease so researchers can find new ways to rescue them.
Brain Health
video
Neuropixels Opto sheds new light into deepest regions of the brain
A single tool measures and manipulates brain cell communication and democratizes advanced neuroscience
neural dynamics
news
.avif)
No results found, try reducing your search parameters.
press & media contact
Get in touch for media inquiries and resources for covering science at the scale of greatest impact.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
The Paul G. Allen Frontiers Group UC Berkeley's Jennifer Doudna a New Allen Distinguished Investigator
The Paul G. Allen Frontiers Group today named Jennifer Doudna, Ph.D., at the University of California, Berkeley an Allen Distinguished Investigator (ADI) with an award for “Antiviral Machinery and Cell Editing Platforms” at the frontier of RNA targeting and cell editing.
The Paul G. Allen Frontiers Group Names UC San Diego's Ethan Bier a New Allen Distinguished Investigator
The Paul G. Allen Frontiers Group today named Ethan Bier, Ph.D., at the University of California, San Diego, an Allen Distinguished Investigator (ADI) with an award for research at the frontier of evolutionary developmental biology titled “Biological Innovation and Active Genetics.”
The Paul G. Allen Frontiers Group Names MIT's James J. Collins a New Allen Distinguished Investigator
The Paul G. Allen Frontiers Group announced today the award of an Allen Distinguished Investigator (ADI) award for “Synthetic Biology Applications to Antimicrobial Resistance” to James J. Collins, Ph.D., at the Massachusetts Institute of Technology, for research at the frontier of antibiotic resistance.
The Paul G. Allen Frontiers Group Names ICM's Bassem Hassan a New Allen Distinguished Investigator
The Paul G. Allen Frontiers Group today named Bassem Hassan, Ph.D., at the Institut du Cerveau et de la Moelle épinière (ICM) in Paris an Allen Distinguished Investigator (ADI) with an award for research at the frontier of neural circuit development and behavior, titled “How developmental noise in neural circuit development determines the unique behavior of individuals.”
No results found, try reducing your search parameters.
